Tadakazu Hisamatsu Selected Research

Inflammatory Bowel Diseases (Inflammatory Bowel Disease)

11/2022	Adrenomedullin for biologic-resistant Crohn's disease: A randomized, double-blind, placebo-controlled phase 2a clinical trial.
1/2022	Genetic Background of Mesalamine-induced Fever and Diarrhea in Japanese Patients with Inflammatory Bowel Disease.
12/2021	Multicenter, cross-sectional, observational study on Epstein-Barr viral infection status and thiopurine use by age group in patients with inflammatory bowel disease in Japan (EBISU study).
1/2021	Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.
9/2020	The shining DIAMOND for evidence-based treatment strategies for Crohn's disease.
6/2020	Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
10/2019	Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine.
8/2019	Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More.
9/2018	NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
1/2018	Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: Management.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadakazu Hisamatsu Research Topics

Disease

49	Ulcerative Colitis 11/2022 - 05/2005
36	Crohn Disease (Crohn's Disease) 11/2022 - 04/2003
28	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 05/2005
25	Colitis 05/2021 - 05/2005
17	Inflammation (Inflammations) 01/2021 - 08/2003
14	Infections 06/2021 - 02/2007
6	Necrosis 05/2022 - 06/2012
5	Abdominal Pain (Pain, Abdominal) 01/2022 - 01/2015
5	Neoplasms (Cancer) 01/2021 - 07/2016
4	Tuberculosis (Tuberculoses) 01/2018 - 01/2018
3	COVID-19 09/2022 - 01/2021
3	Hemorrhage 01/2022 - 01/2010
3	Body Weight (Weight, Body) 02/2020 - 04/2006
3	Ulcer 01/2020 - 11/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 01/2022
2	Anemia 09/2022 - 01/2020
2	Sepsis (Septicemia) 08/2022 - 09/2012
2	Chronic Disease (Chronic Diseases) 06/2022 - 06/2020
2	Herpes Zoster 03/2022 - 10/2019
2	Diarrhea 01/2022 - 06/2015
2	Hypersensitivity (Allergy) 01/2022 - 04/2018
2	Fever (Fevers) 01/2022 - 01/2015
2	Adenoma (Adenomas) 10/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 04/2018
2	Skin Neoplasms (Skin Cancer) 12/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 07/2020 - 01/2014
2	Rectal Neoplasms (Rectal Cancer) 05/2020 - 01/2019
2	Cholangitis 05/2020 - 10/2019
2	Hypoalbuminemia 01/2020 - 01/2007
2	Leukopenia 10/2019 - 09/2018
2	Abscess 11/2018 - 01/2014
2	Pathologic Constriction (Stenosis) 07/2018 - 01/2015
2	Celiac Disease (Celiac Sprue) 02/2018 - 07/2016
1	Arthritis (Polyarthritis) 10/2022
1	Hypoproteinemia 09/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 08/2022

Drug/Important Bio-Agent (IBA)

13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2008
11	Adalimumab (Humira)FDA Link 10/2021 - 01/2014
11	Infliximab (Remicade)FDA Link 03/2021 - 06/2009
11	CytokinesIBA 07/2018 - 08/2003
9	Mesalamine (Mesalazine)FDA LinkGeneric 01/2022 - 12/2012
7	Ustekinumab (CNTO 1275)FDA Link 08/2022 - 01/2019
7	Interleukin-23 (Interleukin 23)IBA 01/2022 - 11/2005
6	Biological ProductsIBA 11/2022 - 07/2019
6	SteroidsIBA 09/2022 - 01/2007
6	2-mercaptopurineIBA 12/2021 - 01/2015
6	Immunologic Factors (Immunomodulators)IBA 09/2020 - 03/2017
5	Monoclonal AntibodiesIBA 01/2020 - 10/2005
5	Interleukin-12 (IL 12)IBA 01/2020 - 11/2005
5	Dextran SulfateIBA 01/2019 - 04/2006
5	AntigensIBA 03/2017 - 10/2005
4	AntibodiesIBA 05/2022 - 09/2020
4	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
4	InterleukinsIBA 01/2022 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 10/2017 - 08/2003
4	RetinoidsIBA 10/2014 - 09/2011
3	tofacitinibIBA 10/2022 - 10/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 10/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2021
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
3	Immunoglobulin G (IgG)IBA 12/2021 - 01/2007
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 05/2021 - 01/2020
3	LactoferrinIBA 05/2021 - 01/2020
3	Azathioprine (Imuran)FDA LinkGeneric 09/2019 - 11/2016
3	Biosimilar PharmaceuticalsIBA 08/2019 - 11/2018
3	EnzymesIBA 09/2018 - 04/2006
3	Interleukin-10 (Interleukin 10)IBA 06/2013 - 03/2010
3	Therapeutic UsesIBA 11/2008 - 05/2005
3	Messenger RNA (mRNA)IBA 11/2008 - 08/2003
2	Janus Kinase InhibitorsIBA 10/2022 - 10/2019
2	Immunoglobulin A (IgA)IBA 05/2022 - 01/2010
2	risankizumabIBA 01/2022 - 01/2022
2	vedolizumabIBA 12/2021 - 09/2021
2	fosfestrol (Kyorin)FDA Link 09/2021 - 08/2019
2	DiamondIBA 09/2020 - 09/2019
2	TabletsIBA 07/2020 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 06/2020 - 05/2005
2	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
2	C-Reactive ProteinIBA 01/2020 - 01/2007
2	Histidine (L-Histidine)FDA Link 01/2015 - 02/2009
2	Prednisolone (Predate)FDA LinkGeneric 01/2015 - 12/2012
2	Capsules (Microcapsules)IBA 09/2014 - 07/2013
2	Bacterial AntigensIBA 05/2013 - 06/2012
2	InterferonsIBA 05/2013 - 11/2012
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2013 - 03/2010
2	Amino Acids FDA Link 01/2012 - 02/2009
2	Dextrans (Dextran)FDA Link 10/2009 - 05/2005
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2009 - 05/2005
1	AdrenomedullinIBA 11/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022
1	Organic Anion TransportersIBA 09/2022
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2022

Therapy/Procedure

37	Therapeutics 03/2022 - 05/2005
4	Colectomy 07/2020 - 11/2010
2	Oral Administration 05/2022 - 12/2013
2	Biological Therapy 01/2022 - 01/2021
2	Punctures 01/2021 - 09/2012
2	Drug Therapy (Chemotherapy) 05/2020 - 11/2006
2	Remission Induction 12/2013 - 03/2013